Option Care Health (NASDAQ:OPCH) Issues Q4 2024 Earnings Guidance

by · The Markets Daily

Option Care Health (NASDAQ:OPCH – Get Free Report) updated its fourth quarter 2024 earnings guidance on Monday. The company provided earnings per share (EPS) guidance of 0.420-0.450 for the period, compared to the consensus estimate of 0.330. The company issued revenue guidance of $1.3 billion-$1.4 billion, compared to the consensus revenue estimate of $1.3 billion. Option Care Health also updated its FY 2024 guidance to 1.550-1.590 EPS.

Option Care Health Stock Up 11.7 %

Shares of OPCH stock opened at $26.80 on Monday. The stock’s fifty day moving average price is $23.10 and its 200 day moving average price is $27.69. Option Care Health has a 1-year low of $21.39 and a 1-year high of $34.63. The company has a market cap of $4.56 billion, a price-to-earnings ratio of 22.52, a price-to-earnings-growth ratio of 2.43 and a beta of 1.31. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on the stock. Truist Financial cut their price objective on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a report on Friday, November 1st. Jefferies Financial Group cut shares of Option Care Health from a “buy” rating to a “hold” rating and decreased their price target for the stock from $38.00 to $26.00 in a report on Thursday, October 31st. The Goldman Sachs Group lowered shares of Option Care Health from a “buy” rating to a “neutral” rating and dropped their price objective for the company from $38.00 to $27.00 in a report on Monday, November 4th. Barrington Research reduced their target price on Option Care Health from $40.00 to $32.00 and set an “outperform” rating for the company in a research note on Thursday, October 31st. Finally, Bank of America downgraded Option Care Health from a “buy” rating to a “neutral” rating and dropped their price target for the company from $43.00 to $29.00 in a research note on Wednesday, October 30th. Four equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Option Care Health presently has an average rating of “Hold” and a consensus target price of $29.14.

Get Our Latest Report on Option Care Health

Insider Activity at Option Care Health

In related news, Director Harry M. Jansen Kraemer, Jr. acquired 43,000 shares of Option Care Health stock in a transaction on Friday, November 8th. The stock was acquired at an average price of $22.54 per share, for a total transaction of $969,220.00. Following the purchase, the director now owns 326,334 shares of the company’s stock, valued at approximately $7,355,568.36. This represents a 15.18 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 0.64% of the stock is currently owned by insiders.

Option Care Health Company Profile

(Get Free Report)

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

Featured Stories